Romiplostim is a fusion protein thrombopoietin (TPO) peptide analog drug. Which increases platelet count by binding to and activating the human fusion protein thrombopoietin receptor. Thrombopoietin receptor agonists work by causing cells in the bone marrow to make more platelets.
Romiplostim is used to treat thrombocytopenia associated with chronic immune thrombocytopenia (ITP).
Romiplostim is used to increase the number of platelets to reduce the risk of bleeding in adults.